Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

Where Apple And Masimo's Watch Patent Fight Stands Now No Photo Available

Theresa Schliep

The high-octane fight between Apple and Masimo over smartwatch patents escalated again last week, when a California federal jury hit A... (more story)

Healthcare Deals This Week: Merck, Sofinnova, Lilly No Photo Available

Yeji Jesse Lee

Merck and Eli Lilly announced billion-dollar transactions set to give them an in on new treatments. Pfizer was victorious after beatin... (more story)

Eye Doc's Hospital Competition Lawsuit Gets NC Panel Trial No Photo Available

Mark Payne

Five years after being denied “certificate of need” application for an eye surgery center, a North Carolina doctor was in court Tuesda... (more story)